BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28027695)

  • 1. Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas.
    Osuka K; Watanabe Y; Usuda N; Aoyama M; Iwami K; Takeuchi M; Watabe T; Takayasu M
    J Neurotrauma; 2017 Jun; 34(11):1996-2000. PubMed ID: 28027695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of JAK-STAT3 signaling pathway in chronic subdural hematoma outer membranes.
    Osuka K; Watanabe Y; Usuda N; Atsuzawa K; Shima H; Takeuchi M; Yasuda M; Takayasu M
    Neurosci Lett; 2013 Feb; 534():166-70. PubMed ID: 23174178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Signal Transducer and Activator of Transcription 3 in Endothelial Cells of Chronic Subdural Hematoma Outer Membranes.
    Osuka K; Watanabe Y; Usuda N; Aoyama M; Kawaguchi R; Watabe T; Takayasu M
    World Neurosurg; 2016 Jul; 91():376-82. PubMed ID: 27102635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 trans-signalling induces vascular endothelial growth factor synthesis partly via Janus kinases-STAT3 pathway in human mesothelial cells.
    Yang X; Lin A; Jiang N; Yan H; Ni Z; Qian J; Fang W
    Nephrology (Carlton); 2017 Feb; 22(2):150-158. PubMed ID: 26869278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of high mobility group B1 and toll-like receptor-nuclear factor κB signaling pathway in chronic subdural hematomas.
    Osuka K; Watanabe Y; Usuda N; Iwami K; Miyachi S; Takayasu M
    PLoS One; 2020; 15(6):e0233643. PubMed ID: 32479555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of Eotaxin-3, Interleukin-5, and Eosinophil-Derived Neurotoxin in Chronic Subdural Hematoma Fluids.
    Kawaguchi R; Osuka K; Aoyama M; Miyachi S; Takayasu M
    J Neurotrauma; 2018 Oct; 35(19):2242-2249. PubMed ID: 29764285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Mitogen-Activated Protein Kinases in Chronic Subdural Hematoma Outer Membranes.
    Aoyama M; Osuka K; Usuda N; Watanabe Y; Kawaguchi R; Nakura T; Takayasu M
    J Neurotrauma; 2015 Jul; 32(14):1064-70. PubMed ID: 25496293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
    Choe JY; Park KY; Park SH; Lee SI; Kim SK
    Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
    Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
    J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps.
    Peters AT; Kato A; Zhang N; Conley DB; Suh L; Tancowny B; Carter D; Carr T; Radtke M; Hulse KE; Seshadri S; Chandra R; Grammer LC; Harris KE; Kern R; Schleimer RP
    J Allergy Clin Immunol; 2010 Feb; 125(2):397-403.e10. PubMed ID: 20159251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble gp130 regulatess interleukin-6 in cerebrospinal fluid after subarachnoid haemorrhage.
    Nakura T; Osuka K; Inukai T; Takagi T; Takayasu M
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):952-4. PubMed ID: 20660911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eotaxin-3 activates the Smad pathway through the transforming growth factor beta 1 in chronic subdural hematoma outer membranes.
    Osuka K; Watanabe Y; Usuda N; Aoyama M; Takeuchi M; Takayasu M
    J Neurotrauma; 2014 Aug; 31(16):1451-6. PubMed ID: 24684589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Caspase Signaling Components in the Outer Membranes of Chronic Subdural Hematomas.
    Osuka K; Watanabe Y; Usuda N; Aoyama M; Iwami K; Takeuchi M; Watabe T; Takayasu M
    J Neurotrauma; 2017 Nov; 34(22):3192-3197. PubMed ID: 28661222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
    Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
    Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
    Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
    Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
    J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
    Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
    Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
    Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
    Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.